Table 1.
Gene | Accession no. | Primer position | Primer sequence | Amplicon Size, bp | References |
---|---|---|---|---|---|
P2Y2 receptor | NM_001302347 | 618–638 756–773 |
GCGTTTCCTCTTCTACACCAA ACCAGCACCCACACAACC |
155 | Designed |
LPL | NM_008509 | 583–604757–777 | AAGCTGGTGGGAAATGATGTGG TTCTGCATACTCAAAGTTAGG |
194 | (36) |
CD36 | NM_001159558 | 794–814 707–726 |
GATGACGTGGCAAAGAACAG TCCTCGGGGTCCTGAGTTAT |
107 | (37) |
HSL | NM_010719 | 1083–1103 1132–1150 |
GGAGCACTACAAACGCAACGA TCGGCCACCGGTAAAGAG |
67 | (38) |
ATGL | NM_001163689 | 724–743 849–868 |
AACACCAGCATCCAGTTCAA GGTTCAGTAGGCCATTCCTC |
144 | (39) |
Insulin receptor | NM_001330056 | 3675–3709 3794–3816 |
TGAGTCAGCCAGTCTTCGAGAA GCCATCAGTTCCATCACTACCA |
141 | Primer finder |
GLUT4 | NM_001359114 | 429–448 482–501 |
GATTCCATCCCACAAGGCAC TCATGCCACCCACAGAGAAG |
72 | (38) |
IRS1 | NM_010570.4 | 1117–1131 1159–1177 |
GAGCGCCCCCAAACG GTCAGCCCGCTTGTTGATG |
60 | (38) |
IRS2 | NM_001081212 | 3214–3233 3285–3302 |
CAAGAGCCCTGGCGAGTACA CCGCGGATGCCAGTAGTG |
88 | (38) |
TNFα | NM_013693 | 533–556 435–456 |
AAGCCTGTAGCCCACGTCGTA GGCACCACTAGTTGGTTGTCTTTG |
121 | (40) |
MCP-1 | NM_011333 | 214–236 404–423 |
CCCAATGAGTAGGCTGGAGA GCTGAAGACCTTAGGGCAGA |
190 | (40) |
CCR2 | NM_009915 | 36–56 152–174 |
GCAAGTTCAGCTGCCTGCAA ATGCCGTGGATGAACTGAGGTAA |
138 | (40) |
CD68 | NM_001291058 | 712–736 788–808 |
CATCAGAGCCCGAGTACAGTCTACC AATTCTGCGCCATGAATGTCC |
96 | (40) |
F4/80 | NM_010130 | 1877–1899 1989–2011 |
GAGATTGTGGAAGCATCCGAGAC GATGACTGTACCCACATGGCTGA |
134 | (40) |
β-Actin | NM_031144.2 | 18–37 205–224 |
CACCCGCGAGTACAACCTTC CCCATACCCACCATCACACC |
207 |